Executive Committee
The Executive Committee is the peak management group of the Kirby Institute. The Executive Committee is responsible for scientific planning, and provides high-level oversight on matters of strategic direction and operational significance to the Institute. The Committee also reviews the advice and recommendations of the Strategic Advisory Group. Members of the Executive Committee are:
| Scientia Professor Anthony Kelleher Director |
| Associate Professor Deborah Cromer
|
| Professor Miles Davenport Program Head, Infections Analytics Program |
| Scientia Professor Gregory Dore Program Head, Viral Hepatitis Clinical Research Program |
| Daren Draganic
|
| Professor Andrew Grulich
|
| Professor Rebecca Guy Program Head, Surveillance and Evaluation Research Program |
| Scientia Professor John Kaldor Program Head, Global Health Program |
| Professor Gail Matthews Program Head, Therapeutic Vaccine and Research Program |
| Robert Monaghan Manager, Aboriginal and Torres Strait Islander Health Research |
| Professor Virginia Wiseman Chair, Strategic Advisory Group |
Strategic Advisory Group
The Strategic Advisory Group will advise the Director and the Executive Committee on matters of strategic and operational significance to support and promote the success, impact and growth of the Kirby Institute. The Strategic Advisory Committee also supports the implementation of the Kirby Strategic Plan and reviews proposals brought forward by the Advisory Committees.
Kirby Institute Strategic Plan 2019–2023
The Kirby Institute Strategic Plan was launched in 2019 with the goal of ensuring that our Institute is the best possible position to respond to the many urgent questions and pressing issues that remain unsolved as we pursue our ultimate goal: a world free from infectious disease.
As we look to the near future, we will be taking what we’ve learnt and applying those insights and approaches to other infectious diseases and to a greater diversity of at-risk communities and populations. We will be building our capacity to discover, develop and implement interventions in our existing and emerging fields of infectious disease research.